R&D performance and relevant factors of renewable energy projects: separating innovation and economic perspectives

por Woo, C., Chun, D.
Publicado 2022

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

por Yuan, Meng, Wu, Nicholas C., Zhu, Xueyong, Lee, Chang-Chun D., So, Ray T. Y., Lv, Huibin, Mok, Chris K. P., Wilson, Ian A.
Publicado 2020

A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody

por Wu, Nicholas C., Yuan, Meng, Bangaru, Sandhya, Huang, Deli, Zhu, Xueyong, Lee, Chang-Chun D., Turner, Hannah L., Peng, Linghang, Yang, Linlin, Nemazee, David, Ward, Andrew B., Wilson, Ian A.
Publicado 2020

Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans

por Zost, Seth J., Lee, Juhye, Gumina, Megan E., Parkhouse, Kaela, Henry, Carole, Wu, Nicholas C., Lee, Chang-Chun D., Wilson, Ian A., Wilson, Patrick C., Bloom, Jesse D., Hensley, Scott E.
Publicado 2019

A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody

por Wu, Nicholas C., Yuan, Meng, Bangaru, Sandhya, Huang, Deli, Zhu, Xueyong, Lee, Chang-Chun D., Turner, Hannah L., Peng, Linghang, Yang, Linlin, Burton, Dennis R., Nemazee, David, Ward, Andrew B., Wilson, Ian A.
Publicado 2020

Neutralizing Antibody Response to Sarbecovirus Is Delayed in Sequential Heterologous Immunization

por Lv, Huibin, So, Ray T. Y., Teo, Qi Wen, Yuan, Meng, Liu, Hejun, Lee, Chang-Chun D., Yip, Garrick K., Ng, Wilson W., Wilson, Ian A., Peiris, Malik, Wu, Nicholas C., Mok, Chris Ka Pun
Publicado 2022

An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain

por Wu, Nicholas C., Yuan, Meng, Liu, Hejun, Lee, Chang-Chun D., Zhu, Xueyong, Bangaru, Sandhya, Torres, Jonathan L., Caniels, Tom G., Brouwer, Philip J.M., van Gils, Marit J., Sanders, Rogier W., Ward, Andrew B., Wilson, Ian A.
Publicado 2020

Structural basis of a public antibody response to SARS-CoV-2

por Yuan, Meng, Liu, Hejun, Wu, Nicholas C., Lee, Chang-Chun D., Zhu, Xueyong, Zhao, Fangzhu, Huang, Deli, Yu, Wenli, Hua, Yuanzi, Tien, Henry, Rogers, Thomas F., Landais, Elise, Sok, Devin, Jardine, Joseph G., Burton, Dennis R., Wilson, Ian A.
Publicado 2020

Structural basis of a shared antibody response to SARS-CoV-2

por Yuan, Meng, Liu, Hejun, Wu, Nicholas C., Lee, Chang-Chun D., Zhu, Xueyong, Zhao, Fangzhu, Huang, Deli, Yu, Wenli, Hua, Yuanzi, Tien, Henry, Rogers, Thomas F., Landais, Elise, Sok, Devin, Jardine, Joseph G., Burton, Dennis R., Wilson, Ian A.
Publicado 2020

Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity

por Liu, Hejun, Wu, Nicholas C., Yuan, Meng, Bangaru, Sandhya, Torres, Jonathan L., Caniels, Tom G., van Schooten, Jelle, Zhu, Xueyong, Lee, Chang-Chun D., Brouwer, Philip J.M., van Gils, Marit J., Sanders, Rogier W., Ward, Andrew B., Wilson, Ian A.
Publicado 2020

Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity

por Liu, Hejun, Wu, Nicholas C., Yuan, Meng, Bangaru, Sandhya, Torres, Jonathan L., Caniels, Tom G., van Schooten, Jelle, Zhu, Xueyong, Lee, Chang-Chun D., Brouwer, Philip J.M., van Gils, Marit J., Sanders, Rogier W., Ward, Andrew B., Wilson, Ian A.
Publicado 2020

A cross-neutralizing antibody between HIV-1 and influenza virus

por Lee, Chang-Chun D., Watanabe, Yasunori, Wu, Nicholas C., Han, Julianna, Kumar, Sonu, Pholcharee, Tossapol, Seabright, Gemma E., Allen, Joel D., Lin, Chih-Wei, Yang, Ji-Rong, Liu, Ming-Tsan, Wu, Chung-Yi, Ward, Andrew B., Crispin, Max, Wilson, Ian A.
Publicado 2021

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection

por Liu, Hejun, Yuan, Meng, Huang, Deli, Bangaru, Sandhya, Lee, Chang-Chun D., Peng, Linghang, Zhu, Xueyong, Nemazee, David, van Gils, Marit J., Sanders, Rogier W., Kornau, Hans-Christian, Reincke, S. Momsen, Prüss, Harald, Kreye, Jakob, Wu, Nicholas C., Ward, Andrew B., Wilson, Ian A.
Publicado 2021

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants

por Yuan, Meng, Huang, Deli, Lee, Chang-Chun D., Wu, Nicholas C., Jackson, Abigail M., Zhu, Xueyong, Liu, Hejun, Peng, Linghang, van Gils, Marit J., Sanders, Rogier W., Burton, Dennis R., Reincke, S. Momsen, Prüss, Harald, Kreye, Jakob, Nemazee, David, Ward, Andrew B., Wilson, Ian A.
Publicado 2021

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants

por Yuan, Meng, Huang, Deli, Lee, Chang-Chun D., Wu, Nicholas C., Jackson, Abigail M., Zhu, Xueyong, Liu, Hejun, Peng, Linghang, van Gils, Marit J., Sanders, Rogier W., Burton, Dennis R., Reincke, S. Momsen, Prüss, Harald, Kreye, Jakob, Nemazee, David, Ward, Andrew B., Wilson, Ian A.
Publicado 2021

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection

por Liu, Hejun, Yuan, Meng, Huang, Deli, Bangaru, Sandhya, Zhao, Fangzhu, Lee, Chang-Chun D., Peng, Linghang, Barman, Shawn, Zhu, Xueyong, Nemazee, David, Burton, Dennis R., van Gils, Marit J., Sanders, Rogier W., Kornau, Hans-Christian, Reincke, S. Momsen, Prüss, Harald, Kreye, Jakob, Wu, Nicholas C., Ward, Andrew B., Wilson, Ian A.
Publicado 2021

Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2

por Zhou, Xiaojuan, Ma, Fengge, Xie, Jun, Yuan, Meng, Li, Yunqiao, Shaabani, Namir, Zhao, Fangzhu, Huang, Deli, Wu, Nicholas C., Lee, Chang-Chun D., Liu, Hejun, Li, Jiali, Chen, Zhonghui, Hong, Yazhen, Liu, Wen-Hsien, Xiao, Nengming, Burton, Dennis R., Tu, Haijian, Li, Hang, Chen, Xin, Teijaro, John R., Wilson, Ian A., Xiao, Changchun, Huang, Zhe
Publicado 2021

Neutralizing Antibodies to SARS‐CoV‐2 Selected from a Human Antibody Library Constructed Decades Ago

por Qiang, Min, Ma, Peixiang, Li, Yu, Liu, Hejun, Harding, Adam, Min, Chenyu, Wang, Fulian, Liu, Lili, Yuan, Meng, Ji, Qun, Tao, Pingdong, Shi, Xiaojie, Li, Zhean, Li, Teng, Wang, Xian, Zhang, Yu, Wu, Nicholas C., Lee, Chang‐Chun D., Zhu, Xueyong, Gilbert‐Jaramillo, Javier, Zhang, Chuyue, Saxena, Abhishek, Huang, Xingxu, Wang, Hou, James, William, Dwek, Raymond A., Wilson, Ian A., Yang, Guang, Lerner, Richard A.
Publicado 2021

Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses

por Dacon, Cherrelle, Peng, Linghang, Lin, Ting-Hui, Tucker, Courtney, Lee, Chang-Chun D., Cong, Yu, Wang, Lingshu, Purser, Lauren, Cooper, Andrew J.R., Williams, Jazmean K., Pyo, Chul-Woo, Yuan, Meng, Kosik, Ivan, Hu, Zhe, Zhao, Ming, Mohan, Divya, Peterson, Mary, Skinner, Jeff, Dixit, Saurabh, Kollins, Erin, Huzella, Louis, Perry, Donna, Byrum, Russell, Lembirik, Sanae, Murphy, Michael, Zhang, Yi, Yang, Eun Sung, Chen, Man, Leung, Kwanyee, Weinberg, Rona S., Pegu, Amarendra, Geraghty, Daniel E., Davidson, Edgar, Doranz, Benjamin J., Douagi, Iyadh, Moir, Susan, Yewdell, Jonathan W., Schmaljohn, Connie, Crompton, Peter D., Mascola, John R., Holbrook, Michael R., Nemazee, David, Wilson, Ian A., Tan, Joshua
Publicado 2023

Broadly neutralizing antibodies target the coronavirus fusion peptide

por Dacon, Cherrelle, Tucker, Courtney, Peng, Linghang, Lee, Chang-Chun D., Lin, Ting-Hui, Yuan, Meng, Cong, Yu, Wang, Lingshu, Purser, Lauren, Williams, Jazmean K., Pyo, Chul-Woo, Kosik, Ivan, Hu, Zhe, Zhao, Ming, Mohan, Divya, Cooper, Andrew, Peterson, Mary, Skinner, Jeff, Dixit, Saurabh, Kollins, Erin, Huzella, Louis, Perry, Donna, Byrum, Russell, Lembirik, Sanae, Zhang, Yi, Yang, Eun Sung, Chen, Man, Leung, Kwanyee, Weinberg, Rona S., Pegu, Amarendra, Geraghty, Daniel E., Davidson, Edgar, Douagi, Iyadh, Moir, Susan, Yewdell, Jonathan W., Schmaljohn, Connie, Crompton, Peter D., Holbrook, Michael R., Nemazee, David, Mascola, John R., Wilson, Ian A., Tan, Joshua
Publicado 2022